Skip to main content
2026 CRT Conference Main banner

Gary Roubin, MD PhD

Chair
CREST2 Trial Interventional Management Committee
Jackson, Wyoming, United States

Dr. Gary Roubin is an internationally renowned interventional cardiologist recognized for his groundbreaking work in the development of the first FDA-approved coronary stent, as well as in pioneering the techniques of carotid stenting, embolic protection devices and large bore femoral closure techniques.
Dr. Roubin has published more than 300 papers in peer reviewed journals. He has edited three textbooks on interventional cardiovascular medicine, coronary, and carotid artery stenting as well as contributing to 20 textbooks on interventional cardiology and vascular medicine. His first book “The First Balloon Expandable Coronary Stent: An Expedition that Changed Cardiovascular Medicine” (Univ. Q Press) is available on amazon.com.

Disclosure(s): Cardiomech Inc: Stock-privately held company (Ongoing); Contego Medical Inc: Stock Options [in privately held companies] (Ongoing); Excision Medical Inc: Stock-privately held company (Ongoing); Inspire MD Inc: Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Presentation(s):

Email Gary